ATROFLEX : ATROFLEX is intended to be used topically and helps to alleviate joint and muscle pain.
ATROFLEX : ATROFLEX is intended to be used topically and helps to alleviate joint and muscle pain.
Atroflex: The product is subjected to a clinical study involving 59 patients in local clinics and results shows 92% patient responded with pain reduction after Atroflex's application.
Atroflex: Biocompatibility testing was done including cytotoxicity, skin irritation and skin sensitization where the results obtained does not indicate any toxicity to human cells.
There were no adverse event/reaction observed since the launch of the product through post market surveillance.
Product is already registered with MDA and is being marketed. Product is already commercialized and being marketed locally and to export market.
In Malaysia, the product can be found in retail pharmacies including Caring, Alpro, Healthlane and others.
Product received endorsement by ISN. There is no trace of any banned substances to be used by athletes and sports enthusiasts.
B2-2, BLOCK RIBOSOM,UKM-MTDC TECHNOLOGY CENTRE, 43650, Bandar Baru Bangi, Selangor, Malaysia
